Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05719337

Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults

Conditions: Left Ventricular Hypertrophy

Sex: All
Ages: 18 Years – N/A
Enrollment: 660
Sponsor: First Hospital of China Medical University

Location: China

Summary

This multicenter clinical study aims to evaluate the multi-modality echocardiographic parameters in patients with different pathological left ventricular hypertrophy (LVH) and investigate the correlation between echocardiographic parameters and different etiologies, providing an important theoretical basis for early identification and risk assessment in LVH patients.

Eligibility Criteria

Inclusion Criteria:Age ≥ 18 years old;A wall thickness ≥ 12mm in one or more LV myocardial segments as measured by 2D echocardiography.Patients with definite diagnosis of hypertensive heart disease, hypertrophic cardiomyopathy, cardiac amyloidosis or Fabry disease.Exclusion Criteria:Patients with severe valvular disease, congenital heart disease, aortic coarctation, multiple Takayasu arteritis, or other cardiovascular diseases that may cause ventricular hypertrophy;Hypertrophy of myocardium caused by high intensity exercise;Poor ultrasonic image quality, which cannot meet analysis requirement.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05719337). StuddyBuddy aggregates publicly available trial information.